FTH

Faeth TherapeuticsA

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-20

View Chart

AI scenario view

RankAlpha Sentiment Codex

B+

Bull case

20%

Probability

Target price

$50.00

+77.4% vs current

Most likely

Base case

50%

Probability

Target price

$30.00

+6.4% vs current

B-

Bear case

30%

Probability

Target price

$17.00

-39.7% vs current

AI sentiment snapshot

Latest data as of 2026-07-19

AI commentary

Recent news flow is moderately positive but primarily event-driven, centered on the PIKTOR program, the company/name transition, and financing. Social coverage, options data, short interest, and employee sentiment are unavailable, and analyst revisions are not present. The deterministic prior remains negative, with expected returns of -0.81% over 5 days, -2.31% over 20 days, and -3.70% over 60 days; this supports a monitoring stance rather than an aggressive bullish conclusion.

RankAlpha Sentiment Codex - 2026-07-19

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-10-17eventPIKTOR Phase 2 endometrial-cancer topline dataHigh impact

Management stated that the Phase 2 FTH-PIK-201 trial remained on track for topline data in the second half of 2026. This is the clearest near-term value inflection, but the outcome remains binary and no efficacy data are yet available. [#SEC-8K-2026-05-15]

2026-10-17catalystRecent CFO open-market purchasesMedium impact

CFO Brian Stephenson reported multiple open-market purchases from June 23 through July 1, 2026. This is a modest sentiment-supporting signal, not evidence of clinical or operating success. [#SEC-FORM4-2026-07-01]

2027-07-19catalystBreast-cancer Phase 1b/2 development progressHigh impact

The first patient was dosed in the FTH-PIK-101 trial for HR+/HER2- advanced breast cancer, with interim data expected in 2027. The program expands the opportunity set but remains early-stage. [#SEC-8K-2026-05-15]

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-07-19 • Updated nightlySource: Internal modelMethodology